KBC Group’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$60K Sell
3,369
-1,823
-35% -$32.5K ﹤0.01% 1512
2025
Q1
$93K Buy
5,192
+101
+2% +$1.81K ﹤0.01% 1521
2024
Q4
$152K Buy
5,091
+2,008
+65% +$60K ﹤0.01% 1299
2024
Q3
$48K Hold
3,083
﹤0.01% 1729
2024
Q2
$53K Hold
3,083
﹤0.01% 1582
2024
Q1
$48K Hold
3,083
﹤0.01% 1579
2023
Q4
$46K Buy
3,083
+182
+6% +$2.72K ﹤0.01% 1587
2023
Q3
$47K Sell
2,901
-7,857
-73% -$127K ﹤0.01% 1497
2023
Q2
$446K Sell
10,758
-34,362
-76% -$1.42M ﹤0.01% 771
2023
Q1
$2.71M Buy
45,120
+38,063
+539% +$2.29M 0.01% 603
2022
Q4
$517K Buy
7,057
+383
+6% +$28.1K ﹤0.01% 758
2022
Q3
$507K Sell
6,674
-32
-0.5% -$2.43K ﹤0.01% 759
2022
Q2
$466K Sell
6,706
-1,983
-23% -$138K ﹤0.01% 773
2022
Q1
$720K Hold
8,689
﹤0.01% 741
2021
Q4
$652K Buy
8,689
+1,720
+25% +$129K ﹤0.01% 800
2021
Q3
$810K Sell
6,969
-6,969
-50% -$810K ﹤0.01% 786
2021
Q2
$3.09M Hold
13,938
0.01% 711
2021
Q1
$1.84M Hold
13,938
﹤0.01% 761
2020
Q4
$13.3M Buy
13,938
+12,390
+800% +$11.8M 0.01% 724
2020
Q3
$172K Hold
1,548
﹤0.01% 1134
2020
Q2
$92K Sell
1,548
-106
-6% -$6.3K ﹤0.01% 1225
2020
Q1
$111K Hold
1,654
﹤0.01% 1127
2019
Q4
$139K Buy
1,654
+1,214
+276% +$102K ﹤0.01% 1326
2019
Q3
$33K Sell
440
-4,334
-91% -$325K ﹤0.01% 1412
2019
Q2
$302K Hold
4,774
﹤0.01% 1166
2019
Q1
$230K Hold
4,774
﹤0.01% 1221
2018
Q4
$160K Hold
4,774
﹤0.01% 1152
2018
Q3
$259K Hold
4,774
﹤0.01% 1233
2018
Q2
$149K Sell
4,774
-1,170
-20% -$36.5K ﹤0.01% 1171
2018
Q1
$130K Buy
5,944
+1,220
+26% +$26.7K ﹤0.01% 1166
2017
Q4
$95K Buy
+4,724
New +$95K ﹤0.01% 1183